Atlas Trials

Dose Escalating Study of a Prototype CS6 Subunit Vaccine With a Modified Heat-labile Enterotoxin From Enterotoxigenic Escherichia Coli (ETEC)

Clinical trial NCT03404674 · COMPLETED

Trial details

NCT number
NCT03404674
Sponsor
PATH
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diarrhea
Start date
2018-01-16
Primary completion
2019-03-26
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.